Menu Back to 01

Track 1: Clinical Safety and Pharmacovigilance

DIA 2017: Driving Insights to Action

This track, with the overarching theme, Big Data – How to Address and Relevance, has 13 sessions providing an overview of the global regulatory environment in the field of clinical safety and pharmacovigilance for medical products (biopharmaceutical products and medical devices), with a focus on pragmatic approaches to protecting patient safety and incorporating the patient voice into the complex and evolving pharmacovigilance ecosystem. Forward-thinking sessions address the application of new technologies and methods to streamline pharmacovigilance systems and processes to enhance protection of patient safety as products become more complex, new data sources drive new analytical techniques, regulatory requirements become more detailed, and medical product development becomes more global.

Sessions in Clinical Safety and Pharmacovigilance

Sunday, June 24 | Short Courses

View All Short Courses

Monday, June 25

Tuesday, June 26

Wednesday, June 27

Thursday, June 28

Who is This Track Designed For?

Professionals involved in: drug safety/pharmacovigilance, medical product safety risk assessment, pharmacoepidemiology (including real world evidence generation), post-market studies (including Large Simple Safety Studies and pragmatic safety studies), statistics, benefit-risk assessment and management, benefit-risk communication (including professional and consumer medical product safety labeling), regulatory affairs, clinical research (including clinical trial design), medical affairs, and health outcomes.

View Other Tracks

Registration Rates

Back to DIA 2018

Back to